Skip to main content
Top

Breast Cancer

Issue 3/2011

Content (15 Articles)

Special Feature

Imaging findings of triple-negative breast cancer

Hiroko Kawashima

Special Feature

Mammography and ultrasound features of triple-negative breast cancer

Yasuyuki Kojima, Hiroko Tsunoda

Special Feature

MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes

Hiroshi Nakahara, Yukiko Yasuda, Eiichiro Machida, Yorio Maeda, Hidemi Furusawa, Kansei Komaki, Mayumi Funagayama, Mayumi Nakahara, Shozo Tamura, Futoshi Akiyama

Special Feature

MR imaging of triple-negative breast cancer

Takayoshi Uematsu

Review Article

Lymphedema and breast cancer: a review of the literature

Stamatakos Michael, Stefanaki Charikleia, Kontzoglou Konstantinos

Erratum

Erratum to: Lymphedema and breast cancer: a review of the literature

Michael Stamatakos, Charikleia Stefanaki, Konstantinos Kontzoglou

Original Article

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane

Yuko Okanami, Yoshinori Ito, Chie Watanabe, Kotaro Iijima, Takuji Iwase, Nahomi Tokudome, Shunji Takahashi, Kiyohiko Hatake

Original Article

Examination of the use of Exemestane in patients with metastatic breast cancer

Seiki Takashima, Sachiko Kiyoto, Mina Takahashi, Fumikata Hara, Daisuke Takabatake, Kenjiro Aogi, Shozo Ohsumi

Original Article

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients

Nahomi Tokudome, Yoshinori Ito, Shunji Takahashi, Kokoro Kobayashi, Shinichiro Taira, Chizuko Tsutsumi, Masafumi Oto, Masaru Oba, Kenichi Inoue, Akiko Kuwayama, Kyoko Masumura, Yoshie Nakayama, Chie Watanabe, Kiyohiko Hatake

Original Article

Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial

Binghe Xu, Zefei Jiang, Sung-Bae Kim, Shiying Yu, Jifeng Feng, Artur Malzyner, Auro del Giglio, Hyun C. Chung, Li Jun Shen, Daniel Lee Kay Pen

Original Article

Radiographic features for triple negative ductal carcinoma in situ of the breast

Yasuyuki Kojima, Hiroko Tsunoda, Satoshi Honda, Mari Kikuchi, Nobue Kawauchi, Atsushi Yoshida, Hiroshi Yagata, Hideko Yamauchi, Koyu Suzuki

Case Report

Parenchymal leiomyoma of the breast: a case report with special reference to magnetic resonance imaging findings and an update review of literature

Shigeki Minami, Shigetoshi Matsuo, Takashi Azuma, Tatsuya Uga, Tomayoshi Hayashi, Susumu Eguchi, Takashi Kanematsu

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine